FDA alert: Zoll LifeVest 4000 may fail to deliver life-saving shocks

The FDA issued a safety alert Jan. 17 for the Zoll LifeVest 4000, saying the external, wearable cardioverter defibrillator may fail to treat potentially fatal arrhythmias if it displays a specific error message which, by itself, doesn’t signal urgency.

According to the FDA, the device may fail to deliver appropriate shock treatment soon after displaying, “Call for service: Device has a problem that may require service. Call ZOLL for service, Message Code 102.” The message is prompted by a fault that prevents the device from charging its high-energy capacitors.

“The ‘Message Code 102’ alert does not explicitly indicate to the patient that the device cannot be used and that the patient should call Zoll immediately,” the FDA’s safety alert said.

The agency is aware of one patient death due to the LifeVest’s failure to deliver treatment after Message Code 102 was displayed. It recommended healthcare providers tell patients how to identify the alert and to call Zoll immediately if they see it.

“Message Code 102 may first display as a gong alert, and then subsequently at every power-up until the device is returned to Zoll for servicing,” the FDA said.

""

Daniel joined TriMed’s Chicago editorial team in 2017 as a Cardiovascular Business writer. He previously worked as a writer for daily newspapers in North Dakota and Indiana.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup